arrow
A

Annalisa Mondi

national institute for infectious diseases lazzaro spallanzani irccs
H指数:20
被引数:1,790

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Burden of advanced HIV disease among antiretroviral therapy-experienced persons with HIV in Italy over the past 20 years

过去20年意大利接受过抗逆转录病毒治疗的人中HIV晚期疾病的负担

2025-08-120
OAAI
Impact of Anti-SARS-CoV-2 Vaccination on Disease Severity and Clinical Outcomes of Individuals Hospitalized for COVID-19 Throughout Successive Pandemic Waves: Data from an Italian Reference Hospital

在连续的大流行浪潮中,Anti-SARS-CoV-2疫苗接种对新型冠状病毒肺炎住院患者的疾病严重程度和临床结局的影响: 来自意大利参考医院的数据

2024-09-062
OAAI
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21
2024-07-192
OAAI
MPXV DNA kinetics in bloodstream and other body fluids samples
2024-06-123
OAAI
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study

根据先前的天花疫苗暴露和HIV感染,改良安卡拉痘苗暴露前疫苗的免疫原性和反应原性: 前瞻性队列研究

2024-02-018
OAAI
Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications
2024-02-0110
OAAI
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox
2023-06-1214
OAAI
Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes

在意大利参考医院因新型冠状病毒肺炎住院的患者中,在Delta和Omicron共循环期间关注的SARS-CoV-2变异的演变: 对临床结果的影响

2023-05-296
OAAI
Temporal intra-host variability of mpox virus genomes in multiple body tissues
2023-05-248
OAAI
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)
2023-03-011
OAAI
Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study
2023-03-0156
OAAI
Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital
2023-01-0118
OAAI